Skip to main content

Anaesthesia for Combined Cardiac and Thoracic Procedures

  • Chapter
  • First Online:
  • 2899 Accesses

Abstract

Combined cardiac and thoracic procedures are rare; however thanks to progress of surgical techniques and recent advances in the use of extracorporeal life support (ECLS) techniques the number of these procedures is increasing.

Anaesthesia and optimal perioperative management for these complex, high-risk surgical interventions requires an expertise in both cardiac and pulmonary physiologies, lung isolation techniques, the multiorgan impact of cardiopulmonary bypass (CPB) and additional monitoring techniques (e.g. transesophageal echocardiography-TEE). Combined procedures may include excision of invasive tumours, pulmonary endarterectomy, cardiac revascularization combined with lung resection and cardiac procedures combined with lung transplantation (e.g. PFO closure). Optimal management of these procedures remains controversial and is not well described; in fact it is mainly limited to case reports (Marseu K et al. A A Case Rep 8:61–63, 2017; Slinger et al. Perioperative care in cardiac anaesthesia and surgery. Lippincott, Williams & Wilkins, Philadelphia/Baltimore/New York/London/Buenos Aires/Hong Kong/Sydney/Tokyo, 43–48, 2006). Proponents of single-stage operations will argue in favour of the avoidance of a second surgery and anaesthetic and reduced hospital stay (Slinger et al. Perioperative care in cardiac anesthesia and surgery. Lippincott, Williams & Wilkins, Philadelphia/Baltimore/New York/London/Buenos Aires/Hong Kong/Sydney/Tokyo, 43–48, 2006; Rao et al. Ann Thorac Surg 62:342-347, 1996). The opponents will argue for divided, two-stage procedures on the basis of limiting surgical trauma, blood loss, multiorgan impact of cardiopulmonary bypass and high intensive care morbidity and thus may potentially confer a better long-term survival (Rao et al. Ann Thorac Surg 62:342-347, 1996; Ciracio et al. Eur J Cardiothorac Surg 22:35–40, 2002).

The following chapter will briefly describe the anaesthetic management for various combined thoracic and cardiac procedures. For a better understanding of why CPB is detrimental for lung function, the author will briefly describe the structure and function of the air-blood barrier and pathophysiology of its injury during procedures with use of CPB.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Marseu K, Minkovich L, Zubrinic M, Keshavjee S. Anesthetic considerations for pneumonectomy with left atrial resection on cardiopulmonary bypass in a patient with lung Cancer: a case report. A A Case Rep. 2017;8:61–3.

    Article  PubMed  Google Scholar 

  2. Slinger PD, Chang DCH, David TE, editors. Perioperative Care in Cardiac Anesthesia and Surgery. Philadelphia/Baltimore/New York/London/Buenos Aires/Homg Kong/Sydney/Tokyo: Lippincott, Williams&Wilkins; 2006. p. 43–8.

    Google Scholar 

  3. Rao V, Todd TRJ, Weisel RD, et al. Results of combined pulmonary resection and cardiac operation. Ann Thorac Surg. 1996;62:342–7.

    Article  CAS  PubMed  Google Scholar 

  4. Ciracio P, Carretta A, Calori G, Mazzone P, Zannini P. Lung resection for cancer in patients with coronary artery disease: analysis of short term results. Eur J Cardiothorac Surg. 2002;22:35–40.

    Article  Google Scholar 

  5. Wąsowicz M, Biczysko W, Marszałek A, Yokoyama S, Nakayama I. Ultrastructural studies on selected elements of the extra cellular matrix in the developing rat lung alveolus. Folia Histochem Cytobiol. 1998;36:3–13.

    PubMed  Google Scholar 

  6. Wąsowicz M, Kashima K, Yokoyama S, Nakayama I. Pulmonary surfactant migrates into the alveolar capillaries of newborn rats an immunoelectron microscopic study. Acta Anat. 1996;156:11–21.

    Article  PubMed  Google Scholar 

  7. Wąsowicz M. Biczysko W. In: Andres J, Wąsowicz M, editors. Selected problems of anesthesia and critical care in cardiovascular surgery. Kraków: Danbert; 2002. p. 174–89.

    Google Scholar 

  8. Wąsowicz M, Drwiła R, Biczysko W, Marszałek A, Florek E, Andres J. Effects of exogenous surfactant on alveolar barrier. An experimental study. Anaesth Inten Ther. 2002;34:76–80.

    Google Scholar 

  9. Wąsowicz M, Sobczyński P, Szulc R, Biczysko W. Ultrastructural changes in the lung alveoli after cardiac surgical operations with the use of cardiopulmonary bypass (CPB). Pol J Pathol. 1999;50:189–96.

    PubMed  Google Scholar 

  10. Ng CSH, Wan S, Yim APC, Arifi AA. Pulmonary dysfunction after cardiac surgery. Chest. 2002;121:1269–77.

    Article  PubMed  Google Scholar 

  11. Biczysko W, Wąsowicz M, Marszałek A. Stromal compartment in the developing lung’s alveoli- an electron microscopic study. Clin Perinat Gynaecol. 1994;6:107–19.

    Google Scholar 

  12. Wąsowicz M, Biczysko W, Sobczyński P. Structure and activity of pulmonary surfactant and their implications for intensive therapy. Inten Care Emerg Med. 1998;1:35–44.

    Google Scholar 

  13. Biczysko W, Wąsowicz M, Metzner J, Marszałek A. In: Drobnik L, Jurczyk W, editors. Problems of anesthesiology and intensive therapy. Warszawa: Wydawnictwo Lekarskie PZWL; 1998. p. 96–109.

    Google Scholar 

  14. Biczysko W, Marszałek A, Wąsowicz M. Maturation of lung epithelia in transmission electron microscopic study. Clin Perinat Gynaecol. 1993;3:3–23.

    Google Scholar 

  15. Doyle I, Nicholas TE, Bernste AD. Serum surfactant protein a levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome. Am J Respir Crit Care Med. 1995;152:307–17.

    Article  CAS  PubMed  Google Scholar 

  16. Sobczyński P, Wąsowicz M. In: Zapalski S, Checinski P, editors. Clinical aspects of lung reperfusion. Clinical aspects of ischemia and reperfusion. Bielsko Biała: Alfa Medica Press; 1997. p. 79–89.

    Google Scholar 

  17. Wąsowicz M, Yokoyama S, Kashima K, Nakayama I. The connective tissue compartment in the terminal region of the developing rat lung. Acta Anat. 1996;156:268–82.

    Article  PubMed  Google Scholar 

  18. Biczysko W, Wąsowicz M, Marszałek A, Florek E. Why do the lungs of premature newborns function improperly? A morphological study of the connective tissue and vascular compartments in the developing lung. Arch Perinat Med. 1999;5:19–26.

    Google Scholar 

  19. Danton MHD, Anikin VA, McManus KG, McGuigan JA, Campalani G. Simultaneous cardiac surgery with pulmonary resection: presentation of series and review of literature. Eur J Cardiothorac Surg. 1998;13:667–72.

    Article  CAS  PubMed  Google Scholar 

  20. Wiebe K, Baraki H, Macchiarini M, Haverich A. Extended pulmonary resections of advanced thoracic malignancies with support of cardiopulmonary bypass. Eur J Cardiothorac Surg. 2006;29:571–8.

    Article  PubMed  Google Scholar 

  21. Dyszkiewicz W, Jemielity M, Piwkowski C, et al. The early and late results of combined off-pump coronary artery bypass grafting and pulmonary resection in patients with concomitant lung cancer and unstable coronary heart disease. Eur J Cardiothorac Surg. 2008;34:531–5.

    Article  PubMed  Google Scholar 

  22. Spaggiari L, D’Aiuto M, Veronesi G, et al. Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass for lung cancer. Ann Thorac Surg. 2005;79:234–40.

    Article  PubMed  Google Scholar 

  23. Voets AJ, Sheik Joesoef K, van Teeffelen MEJM. Synchronously occurring lung cancer (stages I-II) and coronary artery disease: concomitant versus staged surgical approach. Eur J Cardiothorac Surg. 1997;12:713–7.

    Article  CAS  PubMed  Google Scholar 

  24. Wąsowicz M. In: Andres J, Wąsowicz M, editors. Selected problems of anesthesia and critical care in cardiovascular surgery. Kraków: Danbert; 2002. p. 191–207.

    Google Scholar 

  25. Clark SC. Lung injury after cardiopulmonary bypass. Perfusion. 2006;21:225–8.

    Article  PubMed  Google Scholar 

  26. Sharma V, Rao V, Manlhiot C, Boruvka A, Fremes S, Wąsowicz M. A derived and validated score to predict prolonged mechanical ventilation in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2017;153:108–15.

    Article  PubMed  Google Scholar 

  27. Weissman C. Pulmonary complications after cardiac surgery. Semin Cardiothorac Vasc Anesth. 2004;8:185–211.

    Article  PubMed  Google Scholar 

  28. Picone AL, Lutz CJ, Finck C, et al. Multiple sequential insults cause post-pump syndrome. Ann Thorac Surg. 1999;67:978–85.

    Article  CAS  PubMed  Google Scholar 

  29. Tonz M, Milhajevic T, Von Segesser LK. Acute lung injury during cardiopulmonary bypass. Are the neutrophils responsible? Chest. 1995;198:1551–6.

    Article  Google Scholar 

  30. Wąsowicz M, Drwiła R, Sobczyński P, Przybyłowski P, Dziatkowiak A. Lung alveolar damage during coronary artery bypass grafting with use of cardiopulmonary-bypass: and old nemesis? Br J Anaesth. 2000;84(supp 1):18.

    Google Scholar 

  31. Wąsowicz M, Sobczyński P, Drwiła R, Biczysko W, Marszałek A, Andres J. Air-blood barrier injury during cardiac operations with the use of cardiopulmonary bypass (CPB). An old story? Scand Cardiovasc J. 2003;37:216–21.

    Article  PubMed  Google Scholar 

  32. Kotani N, Hashimoto H, Sessler DI, et al. Neutrophil number and interleukin-8 and elastase concentration in bronchoalveolar lavage fluid correlate with decreased arterial oxygenation after cardiopulmonary bypass. Anesth Analg. 2000;90:1046–51.

    Article  CAS  PubMed  Google Scholar 

  33. Kotani N, Hashimoto H, Sessler DI, et al. Cardiopulmonary bypass produces greater pulmonary than systemic proinflammatory cytokines. Anesth Analg. 2000;90:1039–45.

    Article  CAS  PubMed  Google Scholar 

  34. Sinclair DG, Haslam PL, Quinlan GL, Pepper JR, Evans TW. The effects of cardiopulmonary bypass on interstitial and pulmonary endothelial permeability. Chest. 1995;108:718–24.

    Article  CAS  PubMed  Google Scholar 

  35. Kawamura T, Wakusawa R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anesth. 1993;40:1016–21.

    Article  CAS  PubMed  Google Scholar 

  36. Chenoweth DE, Cooper SW, Hugli TE, et al. Complement activation during cardiopulmonary bypass. Evidence for generation C3a and C5a anaphylatoxins. N Engl J Med. 1981;304:497–503.

    Article  CAS  PubMed  Google Scholar 

  37. Warner AE. Pulmonary intravascular macrophages. Role in acute lung injury. Clin Cest Med. 1996;17:125–35.

    Article  CAS  Google Scholar 

  38. Royston D, Fleming JS, Desai JB, et al. Increased production of peroxidation products associated with cardiac operations. Evidence for free radical generation. J Thorac Cardiovasc Surg. 1986;91:75–766.

    Google Scholar 

  39. Wąsowicz M, Drwiła R, Jeleń H, Przybyłowski P, Andres J, Dziatkowiak A. Lipid peroxidation (LO) during cardiac operations with use of cardiopulmonary bypass measured by headspace chromatography. Eur J Anaesthesiol. 2001;18(supp. 22):19.

    Article  Google Scholar 

  40. Wąsowicz M, Drwiła R, Jeleń H, Przybyłowski P, Andres J, Dziatkowiak A. Lipid peroxidation (LO) during cardiac operations with use of cardiopulmonary bypass measured by headspace chromatography. Eur J Anaesthesiol. 2001;18(supp. 22):19.

    Article  Google Scholar 

  41. Rady MY, Ryan T, Star NY. Early onset of acute pulmonary dysfunction after cardiovascular surgery; risk factors and clinical outcomes. Crit Care Med. 1997;25:1831–9.

    Article  CAS  PubMed  Google Scholar 

  42. Magnusson L, Zemgulis V, Wicky ZS, Tyden H, Thelin S, et al. Atelectasis is a major cause of hypoxemia and shunt after cardiopulmonary bypass. Anethesiology. 1997;87:1153–63.

    Article  CAS  Google Scholar 

  43. Bouza E, Perez A, Munoz P, et al. Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance. Crit Care Med. 2003;31:1964–70.

    Article  CAS  PubMed  Google Scholar 

  44. Gaynes R, Bizek B, Movry-Hanley J, et al. Risk factors for nosocomial pneumonia after coronary artery bypass operations. Ann Thorac Surg. 1991;51:215–8.

    Article  CAS  PubMed  Google Scholar 

  45. Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion. 2004;44:1453–62.

    Article  PubMed  Google Scholar 

  46. Taggard DP. Respiratory dysfunction after cardiac surgery: effect of avoiding cardiopulmonary bypass and the use of bilateral internal mammary artery. Eur J Cardiovasc Surg. 2000;18:31–7.

    Article  Google Scholar 

  47. Richter JA, Meisner H, Tassani P, et al. Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting. Ann Thorac Surg. 2000;69:7783.

    Article  Google Scholar 

  48. Minkovich L, Djaiani G, Katznelson R, et al. Effects of alveolar recruitment on arterial oxygenation in patients after cardiac surgery: a prospective, randomized, controlled clinical trial. J Cardiothorac Vasc Anesth. 2007;21:375–8.

    Article  PubMed  Google Scholar 

  49. Tassani P, Richter P, Barankay A, et al. Does high-dose methylprednisolone in aprotinin-treated patients attenuates the systemic inflammatory response during coronary artery bypass grafting procedures? J Cardiothorac Vasc Anesth. 1999;13:165–72.

    Article  CAS  PubMed  Google Scholar 

  50. Saxena P, Tam RKW. Combined off-pump coronary artery bypass surgery and pulmonary resection. Ann Thorac Surg. 2004;78:498–501.

    Article  PubMed  Google Scholar 

  51. Ng CSH, Arifi AA, Wan S, Wai S, Lee TW, Yim APC. Cardiac operation with associated pulmonary resection: a word of caution. Asian Cardiovasc Thorac J. 2002;10:362–4.

    Article  Google Scholar 

  52. Klepetko W. Surgical intervention for T4 lung cancer with infiltration of the thoracic aorta: are we back to the archetype of surgical thinking? J Thorac Cardiovasc Surg. 2005;129:727–9.

    Article  PubMed  Google Scholar 

  53. De Perrot M, Fadel ZE, Mussot S, de Palma A, Chapelier A, Dartevelle P. Resection of locally advanced (T4) non-small cell lung cancer with cardiopulmonary bypass. Ann Thorac Surg. 2005;79:1691–7.

    Article  PubMed  Google Scholar 

  54. Dyszkiewicz W, Jemielity MM, Piwkowski CT, Perek B, Kasprzyk M. Simultaneous lung resection for cancer and myocardial revascularization without cardiopulmonary bypass (off-pump coronary artery bypass grafting). Ann Thorac Surg. 2004;77:1023–7.

    Article  PubMed  Google Scholar 

  55. Mariani M, vn Boven W, Duurkens VAM, et al. Combined off-pump coronary surgery and right lung resections through midline sternotomy. Ann Thorac Surg. 2001;71:1342–4.

    Article  Google Scholar 

  56. Marcucci C, Chassot P-G, Gardaz J-P, Magnusson L, et al. Fatal myocardial infarction after lung resection in a patient with prophylactic preoperative coronary stenting. Br J Anaesth. 2004;92:743–7.

    Article  CAS  PubMed  Google Scholar 

  57. Shudo Y, Takahashi T, Ohta M, et al. Radical operation for invasive thymoma with intracaval, intracardiac and lung invasion. J Card Surg. 2007;22:330–2.

    Article  PubMed  Google Scholar 

  58. Nakajima J, Morota T, Matsumoto J, et al. Pulmonary intimal sarcoma treated by a left pneumonectomy with pulmonary arterioplasty under cardiopulmonary bypass: report of case. Surg Today. 2007;37:496–9.

    Article  PubMed  Google Scholar 

  59. Venuta F, Ciccone AM, Anile M, et al. Reconstruction of the pulmonary artery for lung cancer: long-term results. J Thorac Cardiovasc Surg. 2009;138:1185–91.

    Article  PubMed  Google Scholar 

  60. Ratto GB, Costa R, Vassallo G, et al. Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer. Ann Thorac Surg. 2004;78:234–7.

    Article  PubMed  Google Scholar 

  61. Francesca L, Frazier OH, Radovancevic B, De Caro LF, Reul GJ, Cooley DA. Concomitant cardiac and pulmonary operations for lung cancer. Tex Heart Inst J. 1995;22:296–300.

    PubMed  PubMed Central  Google Scholar 

  62. Lennon PF, Hartigan PM, Friedberg JS. Clinical management of patients undergoing concurrent cardiac surgery and pulmonary resection. J Cardiothorac Vac Anesth. 1998;12:587–90.

    Article  CAS  Google Scholar 

  63. Dowd NP, Karski JM, Cheng DC, Carroll JA, Lin Y, James RL, Butterworth J. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology. 2002;97(2):390–9.

    Article  CAS  PubMed  Google Scholar 

  64. Sharma V, Fan J, Jerath A, Pang KS, Bojko B, Pawliszyn J, Karski JM, Yau T, McCluskey S, Wąsowicz M. Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass. Anaesthesia. 2012 Nov 1;67(11):1242–50.

    Article  CAS  PubMed  Google Scholar 

  65. Jearth A, Yang JQ, Pang KS, Lobby N, Vasicic T, Reyes N, Bojko B, PAwliszyn J, Wijeysundera D, Beattie WS, Wąsowicz M. Tranexamic acid dosing for cardiac surgical patients with chronic renal dysfunction: a new dosing regimen. Anesth Analg. 2018.; published ahead of print

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marcin Wąsowicz .

Editor information

Editors and Affiliations

Case Presentation

Case Presentation

Case

A 21-year-old patient admitted for redo cardiac surgery for resection of recurrent left atrial angiosarcoma invading pulmonary tissue which was demonstrated on a recent follow-up chest X-ray and CT scan (see Figs. 40.6 and 40.7). The proposed procedure will also involve resection of pulmonary parenchyma. His previous surgery was performed 3 years ago without complications and followed by multiple courses of chemotherapy. He has no other significant co-morbidities. Anaesthesiologist is asked to decide whether patient is going to tolerate combined cardiac-thoracic procedure and what additional test he would like to perform.

Fig. 40.6
figure 6

Chest X-ray taken before surgery

Fig. 40.7
figure 7

Computed tomogram showing invasion of the tumour obtained before surgery

Questions

  • What additional tests would you order?

  • Will the patient tolerate procedure? What kind of thoracic procedure will the patient require to achieve complete eradication of his tumour?

  • What is your anaesthetic plan?

  • Do you have any specific concerns related to intraoperative management?

  • What kind of postoperative complications can you expect?

Picture presents intraoperative transesophageal echo findings (Figs. 40.8 and 40.9).

Fig. 40.8
figure 8

Picture obtained during intraoperative, transesophageal examination. Mid-esophageal, four-chamber view

Fig. 40.9
figure 9

Picture obtained during intraoperative, transesophageal examination. Mid-esophageal, two-chamber view

Questions

  • What cardiac procedure should be performed?

  • Which pulmonary veins are invaded?

  • What postoperative complications would you expect?

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wąsowicz, M. (2019). Anaesthesia for Combined Cardiac and Thoracic Procedures. In: Slinger, P. (eds) Principles and Practice of Anesthesia for Thoracic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-00859-8_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-00859-8_40

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-00858-1

  • Online ISBN: 978-3-030-00859-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics